TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.59 CNY | +4.03% |
|
+5.58% | -2.22% |
| Apr. 26 | Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 29 | Dongbao Pharma's 2023 Profit Drops 26% | MT |
Evolution of the average Target Price on Tonghua Dongbao Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
dfbcbe9740637ab3a.8H-sGmugWdEjD6ozNw52a71OYtglzKj3Psr5z5Ai3jY.kwzvcynIFJdqf5kCD1oDCYl-BJt9r86gTaK2jv91nUemM-krX88dqBQi7w~8306446cb2e0725bf5186e1568dbfb18
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
10.59
CNY
Average target price
15.27
CNY
Spread / Average Target
+44.22%
High Price Target
17
CNY
Spread / Highest target
+60.53%
Low Price Target
14
CNY
Spread / Lowest Target
+32.20%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
- Stock Market
- Equities
- 600867 Stock
- Consensus Tonghua Dongbao Pharmaceutical Co., Ltd.
